• RIN3–BIN1 Disruption Drives RAB5 Pathology in AD

  2026-09-02

  Maaser-Hecker and colleagues show that impaired BIN1–RIN3 binding is a causal trigger for RAB5 hyperactivation and enlarged neuronal endosomes, linking AD risk genes to an early trafficking defect. By combining mouse genetics with CRISPR-edited human iPSC-derived neurons, the study provides a mechanistic framework for interpreting RIN3 variants and endosomal pathology in Alzheimer’s disease research.

• Vidarabine monohydrate: Antiviral Workflow Guide

  2026-09-01

  Vidarabine monohydrate is a DMSO-soluble antiviral nucleoside analog for dissecting viral DNA synthesis, replication kinetics, and cell-based antiviral responses. This workflow-focused guide combines practical stock handling, orthogonal readouts, herpes simplex virus research considerations, and troubleshooting strategies for more reproducible experiments.

• CTP Solution (100 mM): Assay Control for mRNA

  2026-09-01

  CTP Solution (100 mM) is more than a nucleotide input: it is an upstream control point for reproducible RNA synthesis and translational assay design. This article connects CTP chemistry and quality control with lessons from localized p21 mRNA-LNP delivery for bladder cancer.

• Toremifene vs Tamoxifen in Advanced Breast Cancer

  2026-08-31

  This Cochrane review assessed whether toremifene provides better tumor control, survival, or tolerability than tamoxifen in advanced breast cancer. Across the included randomized evidence, the two selective estrogen receptor modulators showed broadly comparable clinical outcomes, supporting toremifene as an alternative rather than establishing clear superiority.

• PR-619 in Cell-Based DUB Research Workflows

  2026-08-31

  PR-619 enables reversible, cell-permeable inhibition of multiple cysteine-dependent deubiquitylating enzymes without directly blocking proteasomal catalytic activity. This guide translates that distinction into practical workflows for ubiquitin accumulation, autophagy, oncology, and neurodegeneration assays, with controls designed to separate mechanism from nonspecific toxicity.

• Monomethyl auristatin E: ADC Workflow Guide

  2026-08-30

  Monomethyl auristatin E (MMAE) turns antigen-directed delivery into a measurable microtubule-disruption assay. This guide connects payload handling, ADC benchmarking, and EBV-driven tumor plasticity research without overstating what the current evidence proves.

• Artesunate: Mechanisms and In Vitro Cancer Research

  2026-08-29

  Artesunate is an artemisinin derivative investigated as an anticancer compound in cell-based models. Its reported ferroptosis, caspase-11-mediated pyroptosis, and AKT/mTOR-related effects require assay-specific validation rather than interpretation from a single viability value.

• T7 RNA Polymerase for Precision RNA Workflows

  2026-08-28

  T7 RNA Polymerase enables promoter-specific RNA production from linearized plasmids, PCR products, and compact oligo templates. This guide connects reliable bench workflows with gRNA, mRNA, RNA vaccine production, and antisense RNA applications, while addressing the failure points that most often compromise transcript quality.

• Tin Mesoporphyrin IX (chloride) in Cell Assays

  2026-08-28

  Learn how Tin Mesoporphyrin IX (chloride), SKU C5606, can improve mechanistic interpretation of cell viability, proliferation, and heme oxygenase experiments. This scenario-based guide covers solvent compatibility, concentration design, cross-domain interpretation, and practical product selection.

• Saracatinib: A Mechanism-First Research Guide

  2026-08-27

  Saracatinib (AZD0530) is a selective Src/Abl pathway probe for cancer biology and mechanistic signaling studies. This guide connects kinase pharmacology with assay design, showing how to distinguish proliferation, motility, and synaptic effects without overinterpreting Src inhibition.

• Cy3 TSA Fluorescence System Kit for Cardiac Research

  2026-08-27

  The Cy3 TSA Fluorescence System Kit converts weak immunofluorescence signals into high-density, spatially localized readouts for cardiac tissue, cultured endothelial cells, and nucleic acid assays. This workflow guide connects TSA signal amplification to the endothelial injury model of doxorubicin cardiotoxicity while providing practical setup, optimization, and troubleshooting advice.

• Phosbind Acrylamide for Phosphorylation Assays

  2026-08-26

  Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins directly in an SDS-PAGE workflow. This guide translates the drought-induced SlLHP1b phosphorylation mechanism in tomato into practical gel design, controls, optimization steps, and troubleshooting decisions.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-26

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA to support PCR product contamination elimination and controlled DNA repair workflows. It is intended for research DNA applications, not RNA, oligonucleotides shorter than six bases, diagnostic testing, or medical use.

• From Plant Stress to Quantitative Gene Regulation

  2026-08-25

  A translational framework for converting the SlSTOP1–SlSLAH1 malate-exudation mechanism in tomato into rigorous promoter and transcription-factor experiments using dual-reporter logic, with practical guidance for selecting and deploying a Dual Luciferase Assay System.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-25

  The reference study identifies PP2A-dependent ATG protein phosphorylation as a regulatory link between autophagy, Candida albicans biofilm formation, and antifungal resistance. Its genetic, pharmacological, cellular, and mouse-model experiments suggest that disrupting PP2A-mediated autophagy may improve treatment responses, although the findings remain specific to the tested strain, oral infection model, and experimental conditions.

8527 records 1/569 page Next 12345 下5页 Last page